Decitabine: a promising epi-immunotherapeutic agent in solid tumors. - Wikidata - awgldk - TriplyDB

Decitabine: a promising epi-immunotherapeutic agent in solid tumors.

Decitabine: a promising epi-immunotherapeutic agent in solid tumors.

http://www.wikidata.org/entity/Q38314204

about

Quantitative proteomic analysis of histone modifications in decitabine sensitive and resistant leukemia cell lines DNA demethylating agent decitabine broadens the peripheral T cell receptor repertoire.Contribution of epigenetic mechanisms to variation in cancer risk among tissues.Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes.Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells.Low-dose DNA-demethylating agent enhances the chemosensitivity of cancer cells by targeting cancer stem cells via the upregulation of microRNA-497.Role of epigenetics in modulation of immune response at the junction of host-pathogen interaction and danger molecule signaling.Epigenetic actions of environmental factors and promising drugs for cancer therapy.Differential Regulation of Methylation-Regulating Enzymes by Senescent Stromal Cells Drives Colorectal Cancer Cell Response to DNA-Demethylating Epi-Drugs

P2860

Q37064586-9DC3F918-5FB1-4082-B648-7E3B3D88D4FA Q37437334-C55740F9-2B84-486C-B8E3-304C52F44552 Q37682358-52532EFA-49EF-4A47-8D05-874FF85EDBE9 Q37685237-49949F91-AC65-415A-8393-89640778E1F3 Q38570399-B2DA89EC-A879-4955-B63F-3B720855E6B5 Q38742600-1060784E-B339-41D0-859C-30D7D0FF46B3 Q38778505-82FB0A72-75E4-4198-B524-F9A82DF96363 Q38932108-AFFDAAF1-30EA-4E44-9CD6-0EEB2F0FFA95 Q49724675-E51F7508-0E57-4524-BF93-0541B3FA0935 Q58787924-B4F2E22A-CDE4-4D01-9505-53F20BDCECC1

P2860

Decitabine: a promising epi-immunotherapeutic agent in solid tumors.

http://www.wikidata.org/entity/Q38314204

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Decitabine: a promising epi-immunotherapeutic agent in solid tumors.

@en

type

label

Decitabine: a promising epi-immunotherapeutic agent in solid tumors.

@en

prefLabel

Decitabine: a promising epi-immunotherapeutic agent in solid tumors.

@en

P1433

Q38314204-E1B31AFE-B693-428F-94AA-68C52BA79A47

P1476

Q38314204-A7A61904-397E-4C02-A34E-3520AE8DFF9A

P2093

Q38314204-07823AC3-9AB9-44F0-87A8-1754D1046B77

Q38314204-696A51B2-D542-41F1-9D1A-95B2C6CF4200

Q38314204-6ABD5395-6B8F-49CE-AA18-4FF4E59D3612

Q38314204-B8163C0B-142A-4706-A360-E5C6F088D9BA

Q38314204-C7F61CE3-0471-4B28-9DD5-0DC978CF141A

P2860

Q38314204-0227B4CC-9C20-411C-A785-36ABC5CA885F

Q38314204-0282296E-9D8C-4F49-84F6-0F88AE2696E4

Q38314204-04709304-DF99-4518-A764-5D9EC7C63BED

Q38314204-0933B19F-3E79-4FDB-A879-F3E1F9192FA8

Q38314204-09EE8899-33C0-490D-80FB-2E4A04C5FEDC

Q38314204-0BBB647C-F316-429A-B146-87ABEAD12A7F

Q38314204-0CD2011A-5F26-4005-AC49-AF89CE4EDB6F

Q38314204-1322809F-1A6A-4E9F-A2BC-C7982FAF010B

Q38314204-16C62159-628A-4D00-9B6B-ED8552FB1DF6

Q38314204-185EB9E2-C60A-4FD2-B918-508CDE443B8B

P304

Q38314204-CC8F8C5F-99FA-4C0F-BA56-557FBBC8A9AC

P31

Q38314204-21B7706C-667D-4B9B-983D-413C063C1954

P356

Q38314204-BEE5BB6B-B89E-4B72-80DC-B1C19C1886D6

P433

Q38314204-51DA1D32-22EA-41A8-94D3-F5420D2983FC

P478

Q38314204-18104C33-4DC4-4080-8523-B21F3D2EB5D8

P577

Q38314204-0F2156F3-0C28-46D4-843A-5A1246C5B9D9

P698

Q38314204-4B8969C5-114F-4689-ACE5-5F94A63A3FD5

P921

Q38314204-1142FBE7-8FA8-439D-B167-246F9551925B

P356

1744666X.2015.1002397

P1433

Expert Review of Clinical Immunology

P1476

Decitabine: a promising epi-immunotherapeutic agent in solid tumors.

@en

P2093

Jing Nie

http://www.w3.org/2001/XMLSchema#string

Qian Mei

http://www.w3.org/2001/XMLSchema#string

Weidong Han

http://www.w3.org/2001/XMLSchema#string

Xiang Li

http://www.w3.org/2001/XMLSchema#string

Xiaobing Fu

http://www.w3.org/2001/XMLSchema#string

P2860

DNA vaccines: immunology, application, and optimization*

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia

Cancer immunoediting: from immunosurveillance to tumor escape

Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo

The epigenomics of cancer

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

Epigenetics in cancer

Cooperation between complexes that regulate chromatin structure and transcription

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

P304

363-375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/1744666X.2015.1002397

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25578329

http://www.w3.org/2001/XMLSchema#string

P921